The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
about
Gene of the month: SMARCB1SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH resultsPreclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaDual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)/CK7(pos)/HepPar-1(pos) immunophenotype.The genomic landscape of epithelioid sarcoma cell lines and tumours.Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas.An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case reportHigh-Resolution Genomic Analysis of Cribriform Neuroepithelial Tumors of the Central Nervous System.Atypical teratoid rhabdoid tumors of the posterior fossa in children.INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 CasesSMARCA4-Deficient Carcinoma of Unknown Primary Presenting with Fatal Paraneoplastic Hypercalcemia in a Heart Transplant Recipient: First Report in a Male Patient.Epigenetic Alterations in Bone and Soft Tissue Tumors.SMARCB1-deficient Tumors of Childhood: A Practical Guide.High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases.Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.SMARCA4-deficient Sinonasal Carcinoma.Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.Neck Rhabdoid Tumors: Clinical Features and Consideration of Autologous Stem Cell Transplant.Development of an Atypical Teratoid Rhabdoid Tumor in a Meningioma.Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract.[Grading of soft tissue and bone sarcomas].Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience.Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.Anaplastic thyroid carcinoma with rhabdoid features.Small molecule inhibitors of EZH2: the emerging translational landscape.Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors.Fine-needle-aspiration cytology of a proximal type epithelioid sarcoma: A case report.
P2860
Q26768682-541828CE-6F50-4C94-866A-87B94B326436Q30252961-B87EDACA-E2C9-4A98-AEA9-2B151C62A507Q33276065-97ACB831-E97C-4817-B232-BE9A62CC1ED5Q36071514-9554F111-CCD8-4263-92FC-38F41B5B4475Q36800071-BD5E87AF-297E-4E78-A762-B36699AEB581Q37166723-ADB58163-58F3-42A6-91C1-FFF59BE6990BQ38757918-FD4CE17B-0DBE-4E77-A7A0-B81B9C4F3A5CQ38835609-B4C54784-C816-448F-8F86-EF77408C2AC0Q38862690-F31FDA69-675A-4225-BC20-AA0CE3713210Q39298566-79549459-FFAC-4578-B9B3-B8EBB258689BQ40558893-C546D6B0-6450-4538-9D47-A70AF2E78B9BQ40560695-2A6BD907-89E1-4078-9F7E-D4AB54477663Q40575110-4BD56E19-AE21-46B2-9924-CD13DB1AF755Q47103290-B932CFAD-3730-4ED8-809B-45AC95CCE9EFQ47835503-52FDA75B-E4D5-436A-84D7-92F36133F03AQ47894129-02F502F8-E1C8-4513-9B46-5544BBBF0CCBQ48171014-D4E794F3-C703-4B66-A7BE-464EB0169AECQ48231360-E69FF6BA-0963-4404-9E1A-85D809299D60Q48336422-1DF6D177-C940-43BB-BB21-ED4F64995A57Q48838047-164C3853-D64F-4BDD-8DF6-9AC744020D5BQ49434407-73E90919-15A6-4826-8665-632C6A07405AQ50145215-607E3204-93D5-4D34-8C03-E2B13F65F594Q50750519-91798FC6-0DE8-4651-9D11-5F27D2778240Q51026509-8F2B2A89-18C5-43F9-B4FE-7EF40F97E6F8Q51684531-3F0C3158-0AAC-4811-B19A-0150C0B881ABQ53007905-A21A0394-1CF0-467F-9C7E-847607B0F016Q53331991-6AFCB1C8-8AA5-4296-8D6E-97D9B7D1B2A0Q53611927-12A9D304-6A88-4C6D-858E-71DD24302371Q53637349-CDAA1D6D-0894-4802-BAB5-C0D496BFDE80Q53654363-3103C0B0-A15B-4556-94C4-122DE24B01E7Q53741649-EFE7C8DE-F480-4163-8B8B-D6CD30A1A26FQ54596617-20630FA7-3061-40CD-A2F8-60DD2CFA0204
P2860
The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The expanding family of SMARCB ...... , and molecular heterogeneity.
@en
type
label
The expanding family of SMARCB ...... , and molecular heterogeneity.
@en
prefLabel
The expanding family of SMARCB ...... , and molecular heterogeneity.
@en
P1476
The expanding family of SMARCB ...... , and molecular heterogeneity.
@en
P2093
Abbas Agaimy
P304
P356
10.1097/PAP.0000000000000038
P577
2014-11-01T00:00:00Z